Extended Wear Insulin Device CeQur's FDA-cleared CeQur Simplicity insulin delivery device offers extended wear over 4 days, reducing daily injections and enhancing convenience for users. This unique feature can be highlighted in sales pitches to emphasize the product's efficiency and ease of use.

Recent $120M Equity Financing CeQur secured $120M in equity financing, showcasing investor confidence and providing financial stability for expansion opportunities. This funding injection signifies growth potential and can be leveraged by sales teams to explore new market segments or enhance marketing efforts.

Experienced Board Members With notable appointments like Rick Doubleday and Bradley Paddock to the board of directors, CeQur demonstrates strong leadership and industry expertise. Sales representatives can leverage the credibility of these key personnel to build trust with potential clients and partners.

Competitive Market Positioning In a landscape with companies like Dexcom and Medtronic, CeQur's focus on simplifying insulin delivery stands out. Sales professionals can emphasize the unique selling points of CeQur's products compared to competitors, showcasing the company's innovative approach to diabetes management.

Strategic Technological Integration CeQur utilizes a diverse tech stack including Google Ads, Shopify, and Google Tag Manager, indicating a commitment to leveraging technology for business growth. Sales development teams can capitalize on these tools to enhance customer engagement, streamline operations, and drive sales conversions.